GI Pharmacology Update: Prescribing for Patient Outcome Achievement
Salepage : GI Pharmacology Update: Prescribing for Patient Outcome Achievement
Archive : GI Pharmacology Update: Prescribing for Patient Outcome Achievement Digital Download
Delivery : Digital Download Immediately
Peter Buch, MD, AGAF, FACP
2 Hours 30 Minutes
Audio and Video
Jun 30, 2021
- How do we choose the “best treatment” for Eosinophilic Esophagitis?
- Why are there so many recurrences of Helicobacter pylori?
- What are the best options for treating C. difficile?
Please join Clinical Gastroenterologist Dr. Peter Buch as he explores the answers to these and many other questions in this advanced, case-based, and evidence-supported training event. At the end of this session, you will have new knowledge on the best pharmacologic practices for the most common GI concerns seen in practice.
Peter Buch, MD, AGAF, FACP, is a clinical gastroenterologist with over 30 years of specialty experience to draw from. His current practice is in Manchester, Connecticut where he has assembled a team that treats all GI conditions. “We pride ourselves in giving each patient the time and care they need,” says Dr Buch. This has resulted in outstanding patient evaluations and much better outcomes.
Dr. Buch has a passion for teaching. His style is case based, practical, very interactive and evidence supported. Dr. Buch’s expertise has been shared with experienced clinicians and advanced level students. He teaches at the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, the Frank H Netter School of Medicine/Quinnipiac University and the University of Connecticut APRN School.
Financial: Dr. Peter S. Buch has employment relationships with the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, and the Frank H Netter, MD School of Medicine. He receives a speaking honorarium and recording royalties from PESI, Inc.. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Peter S. Buch serves on the FDA and Patient Care Committees at the American College of Gastroenterology. He serves as an editor of peer-reviewed journals. He is a member of the International Association of Medical Science Educators, the AGA Academy of Educators, the American Gastroenterological Association (AGAF), the American College of Physicians (FACP), the Hartford County Medical Association, the American College of Gastroenterology (FACG), and the Connecticut State Medical Society.
Dr. Buch references the use of antidepressants for Irritable Bowel Syndrome; and the controversial use of Fibrotest to evaluate patients with fatty liver disease who may have fibrosis of the liver. Dr. Buch indicates he wishes to present a fair and balanced approach to practitioners regarding such practices.
More from Categories : Everything Else